
    
      All interested hospital physicians across the UK who prescribe infliximab as part of their
      treatment of Crohn's Disease patients. will be included. It is assumed that the physician
      population will consist primarily of gastroenterologists, though general physicians
      (hospital-based) with an interest in Crohn's Disease may also be included.
    
  